AI Shows Promise in Detecting Heart Transplant Rejection Without Invasive Biopsies
Heart transplant recipients typically undergo regular biopsies—a procedure where tissue is extracted from the heart to check for rejection. This process is invasive and carries risks, including damage to the heart's structures. However, emerging AI technologies may offer a less invasive alternative.
Scientists are training machine learning models to identify rejection patterns using data from blood tests and other non-invasive measurements. These systems analyze biomarkers and physiological signals that correlate with rejection, potentially catching problems earlier than traditional methods allow.
The approach could reduce patient discomfort and healthcare costs while enabling more frequent monitoring. Researchers note that AI-driven monitoring might be particularly valuable for detecting gradual changes that might be missed in occasional biopsies.
Clinical validation studies are still needed before such tools could become standard practice in transplant care, but the technology represents a significant potential shift in how transplant patients are monitored long-term.